SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Nwe Ni Than, Philip N. Newsome, A concise review of non-alcoholic fatty liver disease, Atherosclerosis, 2015, 239, 1, 192

    CrossRef

  2. 2
    S. Michail, M. Lin, M. R. Frey, R. Fanter, O. Paliy, B. Hilbush, N. V. Reo, Altered gut microbial energy and metabolism in children with non-alcoholic fatty liver disease, FEMS Microbiology Ecology, 2015, 91, 2, 1

    CrossRef

  3. 3
    Weiwei Jiang, Na Wu, Xuemei Wang, Yujing Chi, Yuanyuan Zhang, Xinyun Qiu, Ying Hu, Jing Li, Yulan Liu, Dysbiosis gut microbiota associated with inflammation and impaired mucosal immune function in intestine of humans with non-alcoholic fatty liver disease, Scientific Reports, 2015, 5, 8096

    CrossRef

  4. 4
    Michael Fuchs, New Medical Treatment Strategies for Nonalcoholic Steatohepatitis, Current Treatment Options in Gastroenterology, 2015, 13, 2, 259

    CrossRef

  5. 5
    F. W. D. Tai, W.-K. Syn, W. Alazawi, Practical approach to non-alcoholic fatty liver disease in patients with diabetes, Diabetic Medicine, 2015, 32, 5
  6. 6
    Mithun Sharma, Shasikala Mitnala, Ravi K. Vishnubhotla, Rathin Mukherjee, Duvvur N. Reddy, Padaki N. Rao, The Riddle of Nonalcoholic Fatty Liver Disease: Progression From Nonalcoholic Fatty Liver to Nonalcoholic Steatohepatitis, Journal of Clinical and Experimental Hepatology, 2015,

    CrossRef

  7. 7
    J Fernandes, W Su, S Rahat-Rozenbloom, T M S Wolever, E M Comelli, Adiposity, gut microbiota and faecal short chain fatty acids are linked in adult humans, Nutrition & Diabetes, 2014, 4, 6, e121

    CrossRef

  8. 8
    Dina L. Halegoua-De Marzio, Jonathan M. Fenkel, Concepts and Treatment Approaches in Nonalcoholic Fatty Liver Disease, Advances in Hepatology, 2014, 2014, 1

    CrossRef

  9. 9
    Mitchell L Jones, Jorge G Ganopolsky, Christopher J Martoni, Alain Labbé, Satya Prakash, Emerging science of the human microbiome, Gut Microbes, 2014, 5, 4, 446

    CrossRef

  10. 10
    Jennifer E Lambert, Jill A Parnell, Jay Han, Troy Sturzenegger, Heather A Paul, Hans J Vogel, Raylene A Reimer, Evaluation of yellow pea fibre supplementation on weight loss and the gut microbiota: a randomized controlled trial, BMC Gastroenterology, 2014, 14, 1, 69

    CrossRef

  11. 11
    Herbert Tilg, Alexander R Moschen, Evolving therapies for non-alcoholic steatohepatitis, Expert Opinion on Drug Discovery, 2014, 9, 6, 687

    CrossRef

  12. 12
    Noémie Péan, Isabelle Doignon, Thierry Tordjmann, Gut microbiota and bile acids: An old story revisited (again), Clinics and Research in Hepatology and Gastroenterology, 2014, 38, 2, 129

    CrossRef

  13. 13
    Eveliina Munukka, Satu Pekkala, Petri Wiklund, Omid Rasool, Ronald Borra, Lingjia Kong, Xiaowei Ojanen, Shu Mei Cheng, Christophe Roos, Soile Tuomela, Markku Alen, Riitta Lahesmaa, Sulin Cheng, Gut-adipose tissue axis in hepatic fat accumulation in humans, Journal of Hepatology, 2014, 61, 1, 132

    CrossRef

  14. 14
    Bernd Schnabl, David A. Brenner, Interactions Between the Intestinal Microbiome and Liver Diseases, Gastroenterology, 2014, 146, 6, 1513

    CrossRef

  15. 15
    Caroline C. Duwaerts, Jacquelyn J. Maher, Mechanisms of Liver Injury in Non-Alcoholic Steatohepatitis, Current Hepatology Reports, 2014, 13, 2, 119

    CrossRef

  16. 16
    Federica Del Chierico, Daniela Gnani, Pamela Vernocchi, Andrea Petrucca, Anna Alisi, Bruno Dallapiccola, Valerio Nobili, Putignani Lorenza, Meta-Omic Platforms to Assist in the Understanding of NAFLD Gut Microbiota Alterations: Tools and Applications, International Journal of Molecular Sciences, 2014, 15, 1, 684

    CrossRef

  17. 17
    Katherine Bourzac, Microbiome: The bacterial tightrope, Nature, 2014, 516, 7529, S14

    CrossRef

  18. 18
    Benoit Chassaing, Lucie Etienne-Mesmin, Andrew T. Gewirtz, Microbiota-liver axis in hepatic disease, Hepatology, 2014, 59, 1
  19. 19
    Itishree Trivedi, Mary E. Rinella, NAFLD and Cardiovascular Disease: Can the Real Association Be Determined?, Current Hepatology Reports, 2014, 13, 2, 130

    CrossRef

  20. 20
    Miriam B. Vos, Nutrition, nonalcoholic fatty liver disease and the microbiome, Current Opinion in Lipidology, 2014, 25, 1, 61

    CrossRef

  21. 21
    Luc Biedermann, Karin Brülisauer, Jonas Zeitz, Pascal Frei, Michael Scharl, Stephan R. Vavricka, Michael Fried, Martin J. Loessner, Gerhard Rogler, Markus Schuppler, Smoking Cessation Alters Intestinal Microbiota, Inflammatory Bowel Diseases, 2014, 20, 9, 1496

    CrossRef

  22. 22
    Nicolás Velasco, Alvaro Contreras, Bruno Grassi, The mediterranean diet, hepatic steatosis and nonalcoholic fatty liver disease, Current Opinion in Clinical Nutrition and Metabolic Care, 2014, 17, 5, 453

    CrossRef

  23. 23
    Stela Celaj, Michael W Gleeson, Jie Deng, George A O'Toole, Thomas H Hampton, Martin F Toft, Hilary G Morrison, Mitchell L Sogin, Juan Putra, Arief A Suriawinata, James D Gorham, The microbiota regulates susceptibility to Fas-mediated acute hepatic injury, Laboratory Investigation, 2014, 94, 9, 938

    CrossRef

  24. 24
    Patrice D. Cani, When specific gut microbes reveal a possible link between hepatic steatosis and adipose tissue, Journal of Hepatology, 2014, 61, 1, 5

    CrossRef

  25. 25
    Pietro Vajro, Marco Poeta, Luca Pierri, Cristina Pizza, Roberta D’Aniello, Maria Sangermano, Grazia Massa, Giulia Paolella, Nutrition in the Prevention and Treatment of Abdominal Obesity, 2014,

    CrossRef

  26. 26
    Wendy R Russell, Lesley Hoyles, Harry J Flint, Marc-Emmanuel Dumas, Colonic bacterial metabolites and human health, Current Opinion in Microbiology, 2013, 16, 3, 246

    CrossRef

  27. 27
    Fabio Nascimbeni, Raluca Pais, Stefano Bellentani, Christopher Paul Day, Vlad Ratziu, Paola Loria, Amedeo Lonardo, From NAFLD in clinical practice to answers from guidelines, Journal of Hepatology, 2013, 59, 4, 859

    CrossRef

  28. 28
    Pietro Vajro, Claudia Mandato, Roberta D’Aniello, More on Current Evidences on Probiotics as a Novel Treatment for Non-Alcoholic Fatty Liver Disease, Hepatitis Monthly, 2013, 13, 8

    CrossRef

  29. 29
    Alexander R. Moschen, Susanne Kaser, Herbert Tilg, Non-alcoholic steatohepatitis: a microbiota-driven disease, Trends in Endocrinology & Metabolism, 2013, 24, 11, 537

    CrossRef

  30. 30
    Eamonn M Quigley, Howard P Monsour, The gut microbiota and the liver: implications for clinical practice, Expert Review of Gastroenterology & Hepatology, 2013, 7, 8, 723

    CrossRef

  31. 31
    Loek P. Smits, Kristien E.C. Bouter, Willem M. de Vos, Thomas J. Borody, Max Nieuwdorp, Therapeutic Potential of Fecal Microbiota Transplantation, Gastroenterology, 2013, 145, 5, 946

    CrossRef